Adverse drug reactions in the urinary tract

Adverse Drug Reaction Bulletin

Volumn , Issue 193, 1998, Pages 735-738

  Soomro, Naeem A ^a   Neal, David E ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACROLEIN; ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARBENICILLIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DANAZOL; DRUG METABOLITE; ETHER; ISONIAZID; MESNA; METHENAMINE MANDELATE; METHYSERGIDE; METICILLIN; NAFCILLIN; PENICILLIN G; PIPERACILLIN; SPASMOLYTIC AGENT; TIAPROFENIC ACID; TICARCILLIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE;

AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; CYSTIC FIBROSIS; CYSTITIS; ENVIRONMENTAL EXPOSURE; HEMORRHAGIC CYSTITIS; HUMAN; HYDRONEPHROSIS; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MICTURITION; ORAL DRUG ADMINISTRATION; RETROPERITONEAL FIBROSIS; SHORT SURVEY; STRESS INCONTINENCE; URINARY TRACT DISEASE; URINE RETENTION;

EID: 0032429748     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-199812000-00001     Document Type: Short Survey

References (85)

1. Relling MV, Schunk JE. Drug induced hemorrhagic cystitis. Clinical Pharmacy 1986; 5: 590-7.
2. Kende G, Wajsman Z, Thomas PRM, Freeman AI. Chronic hematuria and localized bladder damage following combined cyclophosphamide and local radiotherapy. Journal of Surgical Oncology 1979; 12: 169-74.
3. Jayalakshmamma B, Pinkel D. Urinary-bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy. Cancer 1976; 38: 701-7.
4. Manalo D, Mufson MA, Zollar LM, Mankad VN. Adenovirus infection in acute hemorrhagic cystitis.A study in 25 children. American Journal of Diseases of Children 1971; 121: 281-5.
5. Mufson MA, Belshe RB, Horrigan TJ, Zollar LM. Cause of acute hemorrhagic cystitis in children. American Journal of Diseases of Children 1973; 126: 605-9.
6. Mufson MA, Belshe RB. A review of adenoviruses in the etiology of acute hemorrhagic cystitis. Journal of Urology 1976; 115: 191-4.
7. Klein FA, Smith MJV. Urinary complications of cyclophosphamide therapy: etiology, prevention and management. Southern Medical Journal 1983; 76: 1413-6.
8. Hutter AM, Bauman AW, Frank IN. Cyclophosphamide and severe hemorrhagic cystitis. New York State Journal of Medicine 1969; 29: 305-9.
9. Watson NA, Notely RG. Urological complications of cyclophosphamide. British Journal of Urology, 1973;45: 606-9.
10. Stillwell TJ, Benson RC. Cyclophosphamide-induced hemorrhagic cystitis: a review of 100 patients. Cancer 1988; 61: 451-7.
11. Bennett AH. Cyclophosphamide and hemorrhagic cystitis. Journal of Urology 1974; 111: 603-6.
12. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256-8.
13. Cox PJ. Cyclophosphamide cystitis- identification of acrolein as a causative agent. Biochemical Pharmacology 1979; 28: 2045-9.
14. Renert WA, Berdon WE, Baker DH. Hemorrhagic cystitis and vesicoureteral reflux secondary to cytotoxic therapy for childhood malignancies. American Journal of Roentgenology Radium Therapy and Nuclear Medicine 1973, 117; 664-9.
15. Cook FV, Farrar WE, Kreutner A. Hemorrhagic cystitis and ureteritis, and interstitial nephritis associated with administration of penicillin G. Journal of Urology 1979; 122: 110-11.
16. Philips FS, Sternberg SS, Cronin AP, et al. Cyclophosphamide and urinary bladder toxicity. Cancer Research 1961; 21: 1577-89.
17. Frasier LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991; 42: 781-95.
18. Sladek NE, Smith PC, Bratt PM, et al. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity. Cancer Treatment Reports 1982; 66: 1889-900.
19. Hows JM, Mehta A, Ward L, et al. Comparison of mesna with forced diuresis to to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. British Journal of Cancer 1984; 50: 753-6.
20. Millard RJ. Busulfan-induced hemorrhagic cystitis. Urology 1981; 18: 143-4.
21. Royal JE, Seeler RA. Hemorrhagic cystitis with MOPP therapy. Cancer 1978; 41: 1261-4.
22. Daoud D, Tan J, Fox N. Sterile cystitis associated with chlorambucil. Drug Intelligence and Clinical Pharmacy 1977; 11: 191-2.
23. Yow MD, Taber LH, Barrett FF, et al. A ten-year assessment of methicillin-associated side affects. Pediatrics 1976; 58: 329-34.
24. Bracis R, Sanders CV, Gilbert DN. Methicillin hemorrhagic cystitis. Antimicrobial Agents and Chemotherapy 1977; 12: 438-9.
25. Marx CM, Alpert SE. Ticarcillin-induced cystitis. American Journal of Diseases of Children 1984; 138: 670-2.
26. Sarff LD, McCracken GH, Methicillin associated nephropathy or cystitis. Journal of Pediatrics 1977; 90: 1031-2.
27. Kitzing W, Nelson JD, Mohs E. Comparative toxicities of methicillin and nafcillin. American Journal of Diseases of Children 1981, 135: 52-5.
28. Chudwin DS, Chesney PJ, Mischler EH, Chesney RW. Hematuria associated with carbenicillin and other semisynthetic penicillins. American Journal of Diseases of Children 1979; 133: 98-9.
29. Lurie A, Ogilvie M, Townsend R, Gold C, Meyers AM, Goldberg B. Carbenicillin-induced coagulapathy. Lancet 1970; 1: 1114-5.
30. Brown CH, Natelson EA, Bradshaw MW, Alfrey CP, Williams TW. Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrobial Agents and Chemotherapy 1975; 7: 652-7.
31. Rao GHR, Reddy KR, White JG. Penicillin induced human platelet dysfunction and its reversal with epinephrine. Prostaglandins Leukotrienes and Medicine 1983, 11: 199-211.
32. Moller NE. Carbenicillin induced haemorrhagic cystitis. Lancet 1978; 2: 946.
33. Crawford MLA, Waller PC, Wood SM. Severe cystitis associated with tiaprofenic acid. British Journal of Urology 1997; 79: 578-84.
34. Ghose K. Cystitis and non steroidal anti-inflammatory drugs: an incidental association or an adverse effect? New Zealand Medical Journal 1993; 106: 501-3.
35. Andriole GL, Brickman C, Lack EE, et al. Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. Journal of Urology 1986; 135: 44-6.
36. Bramble FJ, Morley R. Drug induced cystitis; the need for vigilance. British Journal of Urology 1997; 79: 3-7.
37. Tiliakos N, Morales AR, Tsoukalas S. Isoniazid (INH) cystitis. Boletin-Asociacion Medica de Puerto Rico 1980; 72: 527-9.
38. Ross RR, Conway GF. Hemorrhagic cystitis following accidental overdose of methenamine mandelate. American Journal of Diseases of Children 1970; 119: 86-7.
39. Klein FA, Hackler RH. Hemorrhagic cystitis associated with turpentine ingestion. Urology 1980; 16: 187.
40. Lebowitz RL, Effmann EL. Ether cystitis. Urology 1978; 12: 427-8.
41. Folland DS, Kimbrough RD, Cline RE, Swiggart RC, Schaffner W. Acute hemorrhagic cystitis. Industrial exposure to the pesticide chlordimeform. Journal of the American Medical Association 1978; 239: 1052-5.
42. Pras E, Stienlauf S, Pinkhas J, Sidi Y. Urinary retention associated with ipratropium bromide. Annals of Pharmacotherapy 1991; 25: 939-40.
43. Stallard S, Prescot S. Postoperative urinary retention in general surgical patients. British Journal of Surgery 1988; 75: 1141-3.
44. Michelson JD, Lotke PA, Steinberg ME. Urinary bladder management after total joint replacement surgery. New England Journal of Medicine 1988; 319: 321-6.
45. Peterson TK, Husted RE, Rybro L, Schurizek BA, Wernberg M. Urinary retention during i.m. and extradural morphine analgesia. British Journal of Anaesthesia 1982; 54: 1175-8.
46. Hodsman NBA, Kenny GNC, McArdle CS. Patient controlled analgesia and urinary retention. British Journal of Surgery 1988; 75: 212.
47. Niemi L, Pitkanen M, Tuominen M, Rosenberg PH. Technical problems and side effects associated with continuous intrathecal or epidural post-operative analgesia in patients undergoing hip arthroplasty. European Journal of Anaesthesiology 1994; 11: 469-74.
48. Lejus C, Roussiere G, Testa S, Ganansia MF, Meignier M, Souron R. Postoperative extradural analgesia in children: comparison of morphine with fentanyl. British Journal of Anaesthesia 1994; 72: 156-9.
49. Dray A, Metsch R. Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat. Brain Research 1984; 297; 191-5.
50. Dray A, Metsch R. Inhibition of urinary bladder contraction by a spinal action of morphine and other opioids. Journal of Pharmacology and Experimental Therapeutics 1984; 231: 254-60.
51. Malinovsky JM, Le Normand L, Lepage JY, et al. The urodynamic effects of intravenous opioids and ketoprofen in humans. Anaesthesia and Analgesia 1998; 87: 456-61.
52. Kohli-Kumar M, Pearson ADJ, Sharkey I, Craft AW. Urinary retention - an unusual dystonic reaction to continuous metochlorpromide infusion. Annals of Pharmacotherapy 1991; 25: 469-70.
53. Committee on Safety of Medicines. Nefopam hydrochloride (Acupan). Current Problems in Pharmacovigilance 1989 Jan; 24.
54. Nussinovitch M, Soen G, Volovitz I, Vãrsano I, Luttwak PZ. Urinary retention related to phenytoin therapy. Clinical Pediatrics 1995; 34: 382-3.
55. Cohen MAA. Alfonso CA, Mosquera M. Development of urinary retention during treatment with clozapine and meclizine. American Journal of Psychiatry 1994; 151: 619-20.
56. Bryden AA, Rothwell PJN, O'Reilly PH. Urinary retention with misuse of ecstasy. British Medical Journal 1995; 310: 504.
57. Wall LL, Addison WA. Prazosin induced stress incontinence. Obstetrics and Gynecology 1990, 75: 558-60.
58. Atkins FL, Nicolosi GL. Alpha-adrenergic blocking activity of prazosin. Biochemical Pharmacology 1979; 28: 1233-7.
59. Menefee MD, Cheeson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha blockers and angiotensin converting enzyme inhibitors. Obstetrics and Gynecology 1998; 91: 853-4.
60. Donker PJ, Ivanovici F, Noach EL. Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. British Journal of Urology 1972; 44: 180-93.
61. Thien TH, Delaere KPJ, Deburyne FMJ, Koene RA. Urinary incontinence caused by prazosin. British Medical Journal 1978: 1: 622-3.
62. Kiruluta HG, Andrews K. Urinary incontinence secondary to drugs. Urology 1983; 22: 88-90.
63. Madhusoodanan S, Brenner R. Risperidone-induced ejaculatory and urinary dysfunction. Journal of Clinical Psychiatry 1996; 57: 549.
64. Fuller MA, Borovicka MC, Jaskiw GE et al. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. Journal of Clinical Psychiatry 1996; 57: 514-18.
65. Van Putten T, Malkin MD, Weiss MS. Phenothiazine-induced stress incontinence. Journal of Urology 1973; 109: 625-6.
66. Fossaluzza V, Di Benedetto P, Zampa A, De Vita S. Misoprostol-induced urinary incontinence. Journal of Internal Medicine 1991; 230: 463-4.
67. Jonville AP, Echenberger J, Dutertre JP, Autret E. Urapidil and enuresis. Lancet 1992; 339: 688
68. Fantl JA, Wyman JF, Wilson M, et al. Diuretics and urinary incontinence in community dwelling women. Neurourology and Urodynamics 1990; 9: 25-34.
69. Fairchild WV, Spence CR, Soloman HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. Journal of Urology 1979; 122: 163-4.
70. Seo IS, Clark SA, McGovern FD, Clark DL, Johnson EH. Leimyosarcoma of the urinary bladder thirteen years after cyclophosphamide therapy for Hodgkin's disease. Cancer 1985; 55: 1597-1603.
71. Chasko SB, Keuhnelian JW, Gutowski WT, Gray GF. Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis. American Journal of Surgical Pathology 1980; 4: 191-6.
72. Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. New England Journal of Medicine 1975; 293: 271-3.
73. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. New England Journal of Medicine 1988, 318: 1028-32.
74. Laursen B. Cancer of the bladder in patients treated with chlornaphazine. British Medical Journal 1970; 3: 684-5.
75. Bengtsson U, Angervall L, Ekman H, Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scandinavian Journal of Urology and Nephrology 1968; 2: 145-50.
76. van Brommel EFH, Boeve ER, Weimar W. European Board of Urology. Retroperitoneal fibrosis: current concepts. European Urology (Update Series) 1993; 2: 18-23.
77. Graham JR. Methysergide for prevention of headaches; experience of 500 patients after three years. New England Journal of Medicine 1964; 270: 67-72.
78. Pierce JR, Trostle DC, Warner JJ. Propranolol and retroperitoneal fibrosis. Annals of Internal Medicine 1981; 95: 244.
79. Doherty CC, McGeow MG, Donaldson RA. Retroperitoneal fibrosis after treatment with atenolol. British Medical Journal 1978; 2: 1786.
80. Thompson J, Julian DG. Retroperitoneal fibrosis associated with metoprolol. British Medical Journal 1982; 284: 83-4.
81. Laakso M, Arvala I, Tervonen S, Sotarauta M. Retroperitoneal fibrosis associated with sotalol. Britsh Medical Journal 1982; 285: 1085-6.
82. Rimmer E, Richens A, Forster ME, Rees RW. Retroperitoneal fibrosis associated with limolol. Lancet 1983; 1: 300.
83. Rapado A, Traba ML, Caycho C, Cifuentes-Delatte L. Drug induced renal stones: incidence, clinical expression and stone analysis. Contributions to Nephrology 1987; 58: 25-9.
84. Curtis JR. Drug-induced renal disease. Drugs 1979; 18: 377-91.
85. Macdonald JB, Macdonald ET. Nitofurantoin crystalluria. British Medical Journal 1976; 2: 1044-5.